PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models.

PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models.

J Nucl Med. 2011 Nov 9;

Authors: Oude Munnink TH, Arjaans ME, Timmer-Bosscha H,…

This entry was posted in J Nucl Med and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *